Vertex Pharma to Submit Kidney-Disease Drug Application to FDA by Year-End

As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...
IEEE

d-XC Integrals: On the Generalization of the Expanded Form of the Choquet Integral by Restricted Dissimilarity Functions and Their Applications

Abstract: Restricted dissimilarity functions (RDFs) were introduced to overcome problems resulting from the adoption of the standard difference. Based on those RDFs, Bustince et al. introduced a ...